Clinical presentation and treatment of type 2 diabetes in children

Authors

  • Orit Pinhas-Hamiel,

    1. Pediatric Endocrinology and Diabetes Unit, Safra Children’s Hospital, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
    2. Maccabi Juvenile Diabetes Center, Ra’anana, Israel
    Search for more papers by this author
  • Phil Zeitler

    Corresponding author
    1. Division of Endocrinology, The Children’s Hospital, Department of Pediatrics, University of Colorado School of Medicine, Denver, CO, USA
    Search for more papers by this author

Phil Zeitler, MD, PhD
Division of Endocrinology
The Children’s Hospital
University of Colorado School of Medicine
13123 E 16th Avenue
Aurora, CO 80045
USA.
Tel: (303) 861-6128;
fax: (303) 864-5679;
e-mail: phil.zeitler@uchsc.edu

Abstract

Abstract:  Type 2 diabetes mellitus (T2DM) has dramatically increased throughout the world in many ethnic groups and among people with diverse social and economic backgrounds. This increase has also affected the young such that over the past decade, the increase in the number of children and youth with T2DM has been labeled an ‘epidemic’. Before the 1990s, it was rare for most pediatric centers to have significant numbers of patients with T2DM. However, by 1994, T2DM patients represented up to 16% of new cases of diabetes in children in urban areas and by 1999, depending on geographic location, the range of percentage of new cases because of T2DM was 8–45% and disproportionately represented among minority populations. Although the diagnosis was initially regarded with skepticism, T2DM is now a serious diagnostic consideration in all young people who present with signs and symptoms of diabetes in the USA.

Ancillary